The blood spot CardioMetabolic Profile allows early detection of major indicators associated with metabolic/insulin resistance syndrome.

The Fasting Insulin bloodspot is designed to detect insulin resistance (metabolic syndrome), a sign of diabetes, pre-diabetes, and heart disease.

The HbA1c (hemoglobin A1c) test is a blood test used to monitor the status of a patient’s diabetes.

The hs-CRP (High-sensitivity C-Reactive Protein) bloodspot is designed to test for risk of heart disease.

This test requires a blood draw, so please ensure you can refer to a phlebotomist in the clients area before you order this test.

Cardiovascular disease (CVD) is associated with more deaths than all cancers—and more deaths in women than breast cancer. The Cardiovascular Risk Profile reviews a thorough battery of biomarkers to aid in early detection and reduction of risk factors before the disease progresses.